Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 11/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 11/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 9/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 8/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 7/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 7/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.65 |
| ▸ | APP | P05067 | 7/20 | 0.65 |
| ▸ | MAPT | P10636 | 7/20 | 0.65 |
| ▸ | TP53 | P04637 | 6/20 | 0.65 |
| ▸ | AKR1B1 | P15121 | 6/20 | 0.65 |
| ▸ | RECQL | P46063 | 6/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.65 |
| ▸ | HPGD | P15428 | 6/20 | 0.65 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.65 |
| ▸ | XDH | P47989 | 6/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.65 |
| ▸ | LMNA | P02545 | 5/20 | 0.65 |
| ▸ | DAPK1 | P53355 | 5/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quercetin SCHEMBL444562 | 0.83 | MEN1 (0.67) | MEN1KMT2ACYP3A4CYP2C9HSD17B10 | |
| Quercetin SCHEMBL25221565 | 0.83 | MEN1 (0.67) | MEN1KMT2ACYP3A4CYP2C9HSD17B10 | |
| Quercetin SCHEMBL288466 | 0.82 | MEN1 (0.92) | MEN1KMT2ACYP3A4CYP2C9HSD17B10 | |
| Kaempferol SCHEMBL5090719 | 0.82 | MEN1 (0.67) | MEN1KMT2ACYP3A4CYP2C9HSD17B10 | |
| Quercetin SCHEMBL28196529 | 0.82 | MEN1 (0.97) | MEN1KMT2ACYP3A4CYP2C9HSD17B10 | |
| Kaempferol SCHEMBL23070109 | 0.81 | MEN1 (0.73) | MEN1KMT2ACYP3A4CYP2C9HSD17B10 | |
| Quercetin SCHEMBL31507620 | 0.81 | MEN1 (1.00) | MEN1KMT2ACYP3A4CYP2C9HSD17B10 | |
| Quercetin SCHEMBL19723 | 0.81 | MEN1 (1.00) | MEN1KMT2ACYP3A4CYP2C9HSD17B10 | |
| Quercetin SCHEMBL118425 | 0.81 | MEN1 (1.00) | MEN1KMT2ACYP3A4CYP2C9HSD17B10 | |
| Quercetin SCHEMBL29723041 | 0.81 | MEN1 (1.00) | MEN1KMT2ACYP3A4CYP2C9HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
| US-20080044390-A1 | Methods and compositions for the treatment of neurodegenerative disorders | CHDI, INCORPORATED | 2008-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | SERPINC1, SERPINE1, SERPINH1 | MEN1 2457/4885KMT2A 3188/4885CYP3A4 1589/4885 |
| US-20080044390-A1 | Methods and compositions for the treatment of neurodegenerative disorders | HTT, SNCA, NLN | MEN1 3687/4885KMT2A 1354/4885CYP3A4 4801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.